1 The eects of supernatant from the bacterial strain Serratia marcescens 2170 (CS-2170) on the viability of dierent haematopoietic cancer cell lines (Jurkat, NSO, HL-60 and Ramos) and nonmalignant cells (NIH-3T3 and MDCK) was studied. We examined whether this cytotoxic eect was due to apoptosis, and we puri®ed the molecule responsible for this eect and determined its chemical structure.
Introduction
Apoptosis is a form of cell death in which cells actively participate in their own destructive processes. This process is characterized by morphological (Kerr et al., 1994) and biochemical/molecular (Rowan & Fisher, 1997; Reed, 1999; Wickremasinghe & Hobrand, 1999) criteria. Cells undergoing apoptosis shrink and lose their normal intercellular contacts and subsequently exhibit cytoplasmic and chromatin condensation and internucleosomal cleavage of DNA. In the ®nal stages, cells become fragmented into small apoptotic bodies, which are then eliminated by phagocytosis.
Several bacterial pathogens have been identi®ed as mediators of apoptosis in vitro and during pathogenesis (Zychlinsky & Santonetti, 1997) . These pathogens have developed dierent strategies to survive inside the host, overcome natural defences and thus cause disease. Induction of host immunosuppression by triggering apoptosis in phagocytes, like polymorphonuclear neutrophils (PMN) and macrophages, might represent an advantage in bacterial invasion, since these are the most dangerous cells for bacteria. Several pathogens like Shigella spp (Chen & Zychlinsky, 1994) and Salmonella spp Lindgren et al., 1996; Monack et al., 1996) induce apoptosis in macrophages. Furthermore, the induction of PMN apoptosis by Actinobacillus actinomycetemcomitans has been suggested (Kato et al., 1995) .
Bacterial toxins like leukotoxin, a-toxin and hemolysin form pores in the eukaryotic cell membrane and disrupt the cell via osmotic swelling (Mangan et al., 1991; Hildebrand et al., 1991; Jonas et al., 1993) . Other toxins like diphtheria toxin and exotoxin A inhibit protein synthesis, causing apoptosis in eukaryotic cells (Morimoto & Bonavida, 1992; Kochi & Collier, 1993) . Yoshida et al. (1998) identi®ed an acidic glycoprotein puri®ed from the crude extract of Streptococcus pyogenes Su, which showed cell growth inhibition in vitro and antitumour activity in vivo. Verotoxin 1, the active component of the bacteriocin preparation from Escherichia coli, induces apoptosis in human cancer cell lines (Arab et al., 1998) and eliminates human astrocytoma xenografts (Arab et al., 1999) . The prevention of neoplasia by agents from bacteria that inhibit cancer cell proliferation but are not toxic to healthy cells is an exciting prospect. In our laboratory, during screening of potential anticancer drugs, we observed that the supernatant from cultures in stationary phase (growth) of the bacterial strain S. marcescens 2170 induced death in several cancer cell lines. On the basis of this reproducible observation we pursued three objectives. First, we examined the eects of supernatant on the viability of several haematopoietic cancer cell lines and nonmalignant cells and assessed whether this cytotoxic eect was due to apoptosis. Second, we identi®ed the molecule contained in the supernatant of S. marcescens that was responsible for the induction of apoptosis. Third, we puri®ed this molecule and determined its chemical structure. Our results con®rm the molecule as an apoptotic factor with interesting anti-cancer properties.
Methods

Chemical and reagents
Meat peptone was purchased from Difco (Detroit, MI, U.S.A.). Glycerol was bought from Merck (Darmstadt, Germany). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and propidium iodide (PI) were purchased from Sigma Chemicals Co (St Louis, MO, U.S.A.). N-benzyloxycarbonyl-Val-Ala-Asp-¯uoromethyl ketone (Z-VAD.fmk) was obtained from Enzyme Systems Products (Dublin, CA, U.S.A.). Deionized water further puri®ed with a Millipore Milli-Q system (Bedford, MA, U.S.A.). was used.
Bacterial strains
Serratia marcescens 2170 environmental isolated is a wild type strain that produces prodigiosin. Mutants strains of S. marcescens-OF, -WF and -933 were de®cient in prodigiosin biosynthesis (Mody et al., 1990) . NR1 is a lipopolysaccharide (LPS)-de®cient mutant strain of S. marcescens which does not have the O-antigen (Palomar et al., 1993) .
Bacterial cell cultures
Each bacterial strain (S. marcescens-2170, -OF, -WF, -933 and -NR1) was inoculated into 25 ml of peptone glycerol (PG) medium, containing 1% meat peptone and 10% glycerol in distilled water, and cultivated for 8 h at 308C with vigorous shaking, and then transferred to 250 ml of PG medium and cultivated for 48 h at 308C with vigorous shaking. Bacteria were then harvested by centrifugation at 68006g for 15 min at 48C.
Supernatants from the bacterial strains were passed through a 0.22 mm ®lter (Nalge Nunc Int. Rochester, NY, U.S.A.) and concentrated by a centricon 1 Plus-20 (Millipore Iberica, Barcelona, Spain). The resulting concentrated samples (named CS-2170, CS-OF, CS-WF, CS-933 and CS-NR1) were divided into aliquots and stored at 7208C. Protein concentration of the CS were estimated by the Bradford method (Bradford, 1976) , and used as a measure of the CS quantity added to the growth medium of the cell lines.
Cell lines and culture conditions
Acute human T cell leukaemia cells (Jurkat clone E6-1), myeloma cells (NSO), human promyelocytic leukaemia cells (HL-60), human Burkitt lymphoma cells (Ramos), Swiss mouse embryo cells (NIH-3T3) and MDCK (NBL-2) nonmalignant canine epithelial cells were obtained from the American Type Culture Collection (Rockville, MD, U.S.A.). Cells were cultured in RPMI 1640 medium (Biological Industries, Beit Haemek, Israel) except NIH-3T3, which was cultured in DMEM medium (Biological Industries, Beit Haemek, Israel) and MDCK, which was cultured in MEM (Sigma). The three media were supplemented with 10% heatinactivated FBS, 100 u ml 71 penicillin, 100 mg ml 71 streptomycin (all from GIBCO ± BRL, Paisley, U.K.), and 2 mM Lglutamine (Sigma).
Cell viability assay
Cell viability was determined by the MTT assay (Mosmann, 1983) . Brie¯y, 20610 3 cells were incubated in 96-well microtiter cell culture plates, in the absence (control cells) or in the presence of increasing amounts of CS-2170, CS-OF, CS-WF, CS-933 and CS-NR1, in a ®nal volume of 100 ml. After 4 h incubation, 10 mM of MTT (diluted in PBS) was added to each well for an additional 4 h. The blue MTT formazan precipitate was dissolved in 100 ml of isopropanol:1N HCl (24 : 1) and the absorbance at 550 nm was measured on a multiwell plate reader. Cell viability was expressed as a percentage of control. Data are shown as the mean+standard deviation of triplicate cultures.
Analysis of DNA fragmentation
Analysis of DNA fragmentation by agarose gel electrophoresis was performed as described previously (Bellosillo et al., 1997) . Brie¯y, 1610 6 cells per ml were exposured to 10 mg ml 71 of CS-2170, CS-OF, CS-WF, CS-933 and CS-NR1 and incubated overnight (16 h). Cells were washed in PBS and resuspended in ice-cold lysis buer (10 mM Tris-HCl pH 7.4, 1 mM EDTA, 0.2% Triton X-100). After incubating for 15 min at 48C, cell lysates were centrifuged at 14,0006g for 15 min to separate low molecular weight DNA from intact chromatin. The supernatant was treated with 0.2 mg ml 71 of proteinase K in a buer containing (mM) NaCl 150, Tris-HCl 10 pH 8.0, EDTA 40 and 1% SDS for 4 h at 378C. The DNA preparations were phenol/chloroform extracted twice to remove proteins. DNA was precipitated with 140 mM NaCl and two volumes of ethanol at 7208C overnight. DNA precipitates were recovered by centrifugation at 14,0006g for 15 min at 48C, washed twice in cool 70% ethanol and air dried. DNA pellets were resupended in 15 ml of TE (10 mM Tris-HCl pH 8.0, 1 mM EDTA) and treated with RNase-DNase free (Boehringer Mannheim, Mannheim, Germany) for 1 h at 378C. 3.2 ml of loading buer was added to each tube and the DNA preparations were electrophoresed in 1% agarose gels which contained ethidium bromide. Gels were placed on a UV light box to visualize the DNA ladder pattern.
Hoechst staining
Cell morphology was evaluated by¯uorescence microscopy following Hoechst 33342 DNA staining (Sigma Chemicals Co.). Cells (4610 5 per ml) from each cell line were incubated in the absence (control cells) or in the presence of CS-2170 (5 mg ml 71 ) and 300 nM of prodigiosin for 6 h. Cells were then washed in PBS and resuspended in PBS plus Hoechst 33342 to a ®nal concentration of 2 mg ml 71 and incubated for 30 min at 378C in the dark. After incubation, cells were washed in PBS and the sections were examined with a Leitz Diaplan microscope and photographed with a Wild MPS 45 Photoautomat system. Apoptotic cells were identi®ed by features characteristic of apoptosis (e.g. nuclear condensation, formation of membrane blebs and apoptotic bodies).
Analysis of apoptosis by annexin V binding
Exposure of phosphatidylserine was quanti®ed by surface annexin V-FITC (Bender MedSystems, Boehringer Man-nheim) staining as described previously (Koopman et al., 1994; Bellosillo et al., 1998) . 4610 5 cells per ml were incubated for 4 h with 5 and 10 mg ml 71 of CS-2170. After this, cells were washed in PBS and resuspended in 200 ml binding buer (mM: HEPES/NaOH 10 pH 7.4, NaCl 140, CaCl 2 2.5) plus 0.6 ml of annexin V-FITC Kit and incubated for 30 min at room temperature in the dark. After incubation, we added 200 ml of binding buer and propidium iodide to a ®nal concentration of 5 mg ml 71 . Cells were analysed using a Becton Dickinson FACS Calibur¯ow cytometer (Mountain View, CA, U.S.A.). Samples were acquired and analysed using Cell Quest software and data were analysed with the Paint-a-gate Pro software (Becton Dickinson).
Annexin V binds to those cells that express phosphotidylserine on the outer layer of the membrane, and propidium iodide stains the cellular DNA of those cells with a compromised cell membrane. This allows the discrimination of live cells (unstained with either¯uorochrome) from early apoptotic cells (stained only with annexin V) and advanced apoptotic and necrotic cells (stained with both annexin V and propidium iodide).
Puri®cation of prodigiosin
Prodigiosin was extracted by shaking the S. marcescens 2170 cells with a mixture of methanol/1N HCl (24 : 1). After centrifugation (68006g for 15 min), the solvent of the supernatant was evaporated under vacuum. Atmospheric pressure liquid chromatography of the extract was performed on silica gel with chloroform and methanol as solvents. The eluted pigmented fractions were pooled and the chloroform/ methanol extract was vacuum evaporated, redissolved in H 2 O and lyophilized. The isolated pigment was redissolved in methanol and analysed by electrospray ionisation mass spectrometry (ESI-MS) using a VG-Quattro triple quadrupol mass spectrometer (Micromass, VG-Biotech, U.K.). The isolated pigment was repuri®ed by subsequent semipreparative HPLC carried out on a Shimadzu instrument (Kyoto, Japan). A Nucleosil C 18 reversed-phase column (25064 mm, 10 mm) was used with a 0 ± 100% linear gradient in 30 min (A: 0.01 M ammonium acetate, pH 7, B: 100% acetonitrile). The elution was monitored both using diode-array UV detector (SPD-M10AVP Shimadzu) and by ESI-MS. After repeated injections the pooled fractions containing the major peak were vacuum evaporated, redissolved in H 2 O, lyophilized and characterized by ESI-MS and t, 3H) . The concentration of prodigiosin was determined as described (Goldschmidt & Williams, 1968) .
Results
CS-2170 decreased the viability of haematopoietic cancer cells
The eect of the concentrated supernatant from S. marcescens 2170 (CS-2170) on the viability of dierent haematopoietic cancer cell lines (Jurkat, NSO, HL-60 and Ramos) and nonmalignant cell lines (NIH-3T3 and MDCK) was studied. Cell lines were incubated for 4 h with several doses of CS-2170, ranging from 1 to 10 mg ml 71 , and then cell viability was determined by the MTT assay. A dose-dependent decrease in the number of viable cells was observed in all the cell lines studied except NIH-3T3 and MDCK ( Figure 1A ). The IC 50 was 1.45 mg ml 71 for Jurkat, 3.03 mg ml 71 for Ramos, 3.14 mg ml 71 for HL-60 and between 5 and 10 mg ml 71 for NSO. We did not observe a signi®cant decrease in the viability of the NIH-3T3 and MDCK at the doses used in the experiment or in other nonmalignant cell lines like Swiss-3T3. The viability study of these cell lines treated with prodigiosin at dierent times (4 ± 24 h) did not show dierences (data not shown).
CS-2170 induced apoptosis in haematopoietic cancer cells
In order to determine whether this cytotoxic eect was due to apoptosis, we analysed whether CS-2170 induces DNA fragmentation. Agarose gel electrophoresis of DNA showed the characteristic ladder pattern of apoptosis in all haematopoietic cancer cell lines incubated overnight in the presence of 10 mg ml 71 of CS-2170. However, DNA laddering was not observed in the NIH-3T3 and MDCK at this dose of CS-2170 ( Figure 1B) .
We corroborated these results at microscopic level using the Hoechst 33342 staining. Fluorescence microscope allowed the visualization of apoptotic cells with condensed or fragmented nuclei in Jurkat and HL-60 cells but not in NIH-3T3 cells ( Figure 1C) .
Furthermore, we con®rmed these results by measuring apoptosis in the Jurkat cell line by FACS analysis with annexin V-FITC and propidium iodide staining (Figure 2) . We incubated Jurkat cells with 0, 5 and 10 mg ml 71 of CS-2170. The mean values of the early apoptotic populations (IP 7 / Annexin V + cells) were 4+2, 34+8 and 45+3%, respectively. To demonstrate the involvement of caspase activation in the apoptotic eect, we analysed whether the caspase inhibitor Z-VAD.fmk prevented apoptosis (GarcõÂ a-Calvo et al., 1998). When cells were incubated with 0, 5 and 10 mg ml 71 of CS-2170 in the presence of 50 mM Z-VAD.fmk, the mean values of the early apoptotic population were 2+0.2, 3+0.4 and 5+2% respectively. These results show that Z-VAD.fmk inhibits the apoptotic action of CS-2170. Furthermore, Z-VAD.fmk blocked DNA fragmentation (data not shown).
Identi®cation from CS-2170 of the molecule responsible of apoptosis in haematopoietic cancer cells
Samples of CS-2170 were heated to 1008C for 15 min or subjected to dierent protease treatments with trypsin, proteinase K, and protease V8 in order to eliminate active proteins from the sample. In all cases, the samples continued inducing apoptosis (data not shown).
S. marcescens is a Gram-negative bacillus containing LPS, which is responsible for the biological activity of endotoxin and is located in the outer membrane of the bacteria. LPS can be discharged from the outer membrane to the culture medium. In order to rule out LPS as the molecule involved in the apoptosis induced by CS-2170, we used the S. marcescens NR1 mutant which is LPS de®cient. Both CS-2170 and CS-NR1 induced similar DNA laddering pattern (Figure 3 ), indicating that LPS is not responsible for the apoptotic action.
Samples from mutants defective in prodigiosin biosynthesis ( Figure 4 ) were examined to clarify the involvement of this pigment in the apoptosis activity observed. Prodigiosin (2-methyl-3-pentyl-6-methoxyprodigiosene) is synthesized in S. marcescens by the coupling of 2-methyl-3-n-amylpyrrole (MAP) with 4-methoxy-2,2'-bipyrrole-5-carboxaldehyde (MBC). Mutant OF does not form MBC, but forms 4-hydroxy-2,2'-bipyrrole-5-carboxaldehyde (HBC) instead, which couples with MAP to form norprodigiosin (2-methyl-3-pentyl-6-hydroxyprodigiosene). Mutant WF does not form HBC or MBC but forms the volatile pyrrole MAP. Mutant 933 does not form MAP but forms MBC (Mody et al., 1990) Figure 4 . Only CS-2170 and CS-OF induced a signi®cant decrease in the viability of Jurkat cells ( Figure  5A ), and the characteristic DNA ladder pattern of apoptosis ( Figure 5B ). CS-WF and CS-933 decreased cell viability but with less eciency than CS-2170 and CS-OF and with no evidence of DNA laddering ( Figure 5B) . Furthermore, the addition of puri®ed prodigiosin to CS-WF and CS-933 allowed the induction of apoptosis in Jurkat cells (data not shown). These evidences indicate that prodigiosin and norprodigiosin (produced by OF mutant) are involved in this apoptosis.
Puri®cation and characterization of prodigiosin from CS-2170 as the apoptotic factor synthesized from S. marcescens 2170 Furthermore, the apoptotic factor was puri®ed by methanol/ HCl extraction followed by silica gel chromatography and semipreparative reverse-phase HPLC. Electrospray ionization mass spectrometry gave a molecular weight of 323.4, consistent with the expected value for prodigiosin (C 20 H 25 N 3 O) . The structure of prodigiosin was further con®rmed by high-®eld 1 H-NMR spectroscopy. Jurkat and NIH-3T3 cell lines were incubated with 60 to 1200 nM of prodigiosin for 4 h, and cell viability was determined by MTT assay. Prodigiosin decreased viability of Jurkat cells. The IC 50 was higher for the NIH-3T3 cells ( Figure 6A ). The DNA fragmentation pattern and was observed in Jurkat cells but not in NIH-3T3 cells ( Figure 6B) . The nuclei shown a strong blue¯uorescence and were condensed and fragmented in Jurkat cells ( Figure 6C ). Furthermore, we con®rmed these results by measuring apoptosis in Jurkat cells by FACS analysis with annexin V-FITC and propidium iodide staining ( Figure 6D ). We incubated the cells with 0, and 300 nM of prodigiosin. The mean values of the early apoptotic populations (IP 7 /Annexin V + cells) were 3+0.7 and 38+2%, respectively.
Discussion
Apoptosis is involved in the action of several cancerchemotherapeutic agents. In the last few years, the selection of new drugs associated with apoptosis that would be expected to be eective against tumours with high proliferation like leukemias and lymphomas has been introduced into screening for new anticancer drugs (Cameron & Feuer, 2000) . Our ®ndings demonstrate that prodigiosin released from S. marcescens 2170 to the culture medium induced apoptosis in four haematopoietic cancer cell lines (Jurkat, NSO, HL-60 and Ramos) but not in nonmalignant cells (NIH-3T3 and MDCK). Furthermore, prodigiosin is equally active in other cancer cell lines like SW-620, DLD-1 and HGT-1 (all of gastrointestinal origin) (Montaner et al., manuscript in preparation), and indicates that prodigiosin may have potential as new antineoplastic candidate. S. marcescens is a ubiquitous bacterium inhabiting water, soil, plants, insects and vertebrates, and it has various characteristics including the pigment prodigiosin (Hejazi & Falkiner, 1997) . We decided to study the possible involvement of prodigiosin in this apoptosis for dierent reasons: (a) in our culture conditions the supernatant from S. marcescens 2170 was always red, the characteristic colour of prodigiosin; (b) prodigiosin should be stable at 1008C and protease-resistant (both properties are in accordance with our previous experiments); (c) immunosuppressive activity has been described for prodigiosin family members (Tsuji et al., 1992; Kawauchi et al., 1997; Songia et al., 1997; Han et al., 1998) ; and (d) the immunosuppressive eects of prodigiosin family members may be due to their apoptotic eects as Kawauchi et al., (1997 ) and, recently, Azuma et al. (2000 suggested. (7) or incubated overnight (16 h) with 10 mg ml 71 of CS-2170 and CS-NR1. DNA was extracted and subjected to agarose gel electrophoresis as described in Methods.
Prodigiosin is produced by S. marcescens, Pseudomonas magnesiorubra, Vibrio psychroerythrus and other bacteria (Gerber, 1975; Paruchuri & Harshey, 1987) . Microscopic observations of S. marcescens colonies showed that prodigiosin pigment was localized in vesicles (extracellular and cell associated) or intracellular granules (Matsuyama et al., 1986; Kobayashi & Ichikawa, 1991) . This pigment is synthesized in a bifurcated pathway, in which mono-and bipyrrole precursors are synthesized separately and then coupled to form prodigiosin (Boger & Patel, 1988) . Although, we can not rule out the possibility that CS-2170 has other minor proapoptotic components, our results using dierent mutant strains of S. marcescens indicate that prodigiosin and/or norprodigiosin, with very similar chemical structure, are involved in the apoptotic activity (Figure 4) . Identi®cation by spectroscopic analysis of prodigiosin released from S. marcescens to the culture medium, allow us to demonstrate that it is responsible for the induction of apoptosis in haematopoietic cancer cells. Recently, Han et al. (1998) described a T-cell speci®c immunosuppression associated to prodigiosin; however, they showed that prodigiosin did not cause signi®cant decrease in the splenic lymphocyte viability for 24 h of incubation at concentrations from 1 to 1000 nM, similar to our results in nonmalignant NIH-3T3 cells ( Figure 6A ).
Prodigiosin 25-C (UP) and cycloprodigiosin hydrochloride (cPrGHCl), two members of the prodigiosin family, synthesized by Streptomyces spp and Pseudoalteromonas denitri®cans respectively have been identi®ed to have immunosuppressive activity (Tsuji et al., 1992; Kawauchi et al., 1997; Songia et al., 1997) . UP inhibits equally well both T and B human lymphocyte proliferation, but not transformed leukaemic cell lines (Songia et al., 1997) ; Songia et al. (1997) suggested that cell-cycle related proteins such as retinoblastoma (Rb) and cyclin-dependent Kinase-2 and -4 (Cdk-2 and Cdk-4) are the target molecules of UP to induce growth arrest in G 1 phase in human T and B lymphocytes. Recently, Mortellaro et al. (1999) reported that a synthetic analogue of UP, PNU156804, has a biological eect indistinguishable from UP and eciently inhibits the activation of NF-kB and AP-1 transcription factors. Inhibition of NF-kB substantially enhances the apoptotic potential of cancer therapies (Wang et al., 1999) . However, Kawauchi et al. (1997) and Azuma et al. (2000) suggested that apoptosis is the mechanism of action of cPrGHCl to induce suppression of T cell proliferation. The molecule cPrGHCl inhibits proliferation and induces apoptosis in hepatocellular carcinoma cell lines, showing IC 50 values from 276 to 592 nM, compared with 8395 nM in isolated normal rat hepatocytes, at 72 h (Yamamoto et al., 1999) . Our results show an IC 50 for prodigiosin of 225 nM in Jurkat in a shorter assay (4 h). However, the mechanisms underlying the apoptotic eect of prodigiosin are unknown. cPrGHCl inhibits vacuolar ATPase (Tsuji et al., 1992) , and, like other vacuolar ATPase inhibitors, it acidi®es the cytoplasm and apoptosis (Gottlieb et al., 1996) . The results presented in this report show that prodigiosin-induced apoptosis is blocked by Z-VAD.fmk, indicating that these caspases are involved in prodigiosininduced apoptosis in haematopoietic cancer cell lines. Interestingly, prodigiosin induces apoptosis in Jurkat and HL-60 cells, both of which are p53 de®cient (Chen & Haas, 1990) . This evidence indicates that prodigiosin-induce apop- Jurkat and NIH-3T3 cell lines were incubated with 60 to 1200 nM of prodigiosin for 4 h. Cell viability was determined by the MTT assay as described in Methods and it is expressed as a percentage with respect to control cells. (B) DNA fragmentation induced by prodigiosin. 1610 6 Jurkat and NIH-3T3 cells in 1 ml were untreated (7) or incubated (P) with 300 nM of prodigiosin for 16 h. DNA was extracted and subjected to agarose gel electrophoresis as described in Methods. (C) Fluorescence microscopic analysis of Jurkat and NIH-3T3 nuclei with Hoechst 33342 staining. Jurkat and NIH-3T3 cells were untreated (7Prodigiosin) or treated (+Prodigiosin) with 300 nM of prodigiosin for 6 h (bar=10 mm). (D) Detection of apoptosis in Jurkat cells detected by annexin-V/ PI assay after 4 h exposure to 300 nM of prodigiosin.
tosis by a p53-independent mechanism. Oncogenesis is often associated with defects in p53. As prodigiosin-induced apoptosis is p53-independent, this could mean an advantage over other chemotherapeutic drugs (Brown & Wouters, 1999; Bunz et al., 1999) .
The elucidation of the mechanisms involved in the apoptotic action of prodigiosin and its evaluation as a possible anticancer drug warrants further investigation.
